Howard Colman, MD
Neurology · Salt Lake City, UTNPI 1437258498
Payments from drug & device makers
Across 263 payments — averaging $5280.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Karyopharm Therapeutics Inc.$382K
- Array Biopharma Inc$198K
- Sumitomo Pharma America, Inc.$176K
- E.r. Squibb & Sons, L.L.C.$167K
- Novartis$142K
- Beigene, Ltd.$112K
- plus $211K from 9 others
Across 9 payments — averaging $1298.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$7K
- Servier Bioinnovation$4K
- Servier Pharmaceuticals LLC$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Karyopharm Therapeutics Inc. | 59 | $382,344 |
| Array Biopharma Inc | 41 | $198,266 |
| Sumitomo Pharma America, Inc. | 18 | $176,122 |
| E.r. Squibb & Sons, L.L.C. | 16 | $167,154 |
| Novartis | 5 | $142,355 |
| Beigene, Ltd. | 47 | $111,520 |
| Novocure GmbH | 3 | $79,038 |
| Deciphera Pharmaceuticals Inc. | 32 | $53,787 |
| Bayer | 20 | $51,720 |
| Kadmon Corporation LLC | 2 | $9,925 |
| Regeneron | 14 | $7,220 |
| Servier Pharmaceuticals LLC | 3 | $4,300 |
| Novocure Inc. | 1 | $4,020 |
| Merck | 1 | $531 |
| Roche Molecular Systems, Inc. | 1 | $400 |
How this compares
$1,388,702 in reported general payments places this provider in the 95th percentile of 157 neurology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Salt Lake City
- April ErwinSalt Lake City$3.9M
- Nicholas JohnsonSalt Lake City$3.7M
- Norman FosterSalt Lake City$2.7M
- Stacey ClardySalt Lake City$2.1M
- John FoleySalt Lake City$1.9M
- Paolo MorettiSalt Lake City$1.8M
- Edward ZamriniSalt Lake City$1.1M
- Mark BrombergSalt Lake City$932K
- Summer GibsonSalt Lake City$899K
- Timothy WestSalt Lake City$889K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.